Page results
-
An immunotherapy drug given before surgery instead of chemotherapy meant that significantly more patients with a certain genetic profile were cancer free after surgery, according to clinical trial results presented by researchers at UCL and UCLH.
-
UCLH Find & Treat team explain why screening is vital on World Hepatitis Day
-
The hospital marked the start of the year a visit by HM The Queen in February 2020. A few weeks after this celebration, the pandemic took hold and the hospital stepped up to help.
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
The Sickle Cell Society (SCS) and the UK Thalassaemia Society (UKTS) have worked in partnership with the NHS sickle cell and thalassaemia (SCT) screening programme to engage with communities less likely to access health information through usual NHS channels. The societies provide feedback from people that share the same population background or have experience of the condition and to feed into the programme updates and improvements.
-
Education and training videos for Red Cell Network patients
-
Patient information for Red Cell Network patients
-
A study of patients at UCLH and North Middlesex University Hospital published in The Lancet Infectious Diseases suggests that the B.1.17. variant of Covid-19 is not associated with more severe illness and death, but appears to lead to higher virus load.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
File results
-
FOI/2023/0497 - List of all laboratories within Pathology
-
FOI/2023/0493 - Treatments for various diseases
-
FOI/2023/0491 - Treatment for oesophageal and gastric cancer
-
FOI/2023/0488 - Electronic Patient Record (EPR)
-
FOI/2023/0614 - Communications
-
FOI201730 Cancelled cancer operations
-
FOI201731 Multiple sclerosis patients treated with MS disease modifying drugs
-
FOI201725 Female genital mutilation
-
FOI201732 Occupational Therapy lead
-
FOI201738 Patient safety within maternity services